Thinking about your myeloma on a high level can be just as important as knowing the details of your care. Who gets myeloma and why? Is your family at risk of getting it? And what strategies should you as a patient understand as you go through treatment for your disease?

Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease.

If you register in HealthTree to use HealthTree University (where you can watch these same videos), you can save and keep track of your progress, get points for answering quiz questions, bookmark videos, take notes, earn prizes [COMING SOON], and get access to all the other features of HealthTree.

 

Join HealthTree

 

3.01 - How prevalent is myeloma in the US?

Featuring: 

• Muzaffar Qazilbash, MD of MD Anderson Cancer Center

3.02 - What are the risk factors for developing myeloma?

Featuring: 

• Muzaffar Qazilbash, MD of MD Anderson Cancer Center

3.03 - Is my family at risk of developing myeloma?

Featuring: 

• Irene Ghobrial, MD of Dana-Farber Cancer Institute

3.04 - How are overall strategies developed for patients with myeloma?

Featuring: 

• Aaron Rosenberg, MD, MS of UC Davis Comprehensive Cancer Center

3.05 - What long-term strategies should myeloma patients understand?

Featuring: 

• Aaron Rosenberg, MD, MS of UC Davis Comprehensive Cancer Center

Want more?

We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

Other HealthTree University Classes:

1. Myeloma Basics Part 1
2. Myeloma Basics Part 2
3. Myeloma Basics Part 3
4. Building Your HealthCare Team
5. Becoming an Empowered Patient
6. Starting Myeloma Treatment
7. Autologous Stem Cell Transplant (ASCT)
8. Precursor Conditions
9. Relapsed and Refractory MM Treatment
10. Myeloma Bone Disease
11. Testing, Monitoring MM Markers
12. [BETA] Multiple Myeloma Genetics and Precision Medicine
13. Classes of Myeloma Drugs
14. [BETA] COVID-19 and Multiple Myeloma